期刊文献+

sEng与sFlt-1在子痫前期患者血清中的表达及意义 被引量:8

暂未订购
导出
摘要 目的探讨可溶性endoglin(sEng)和可溶性血管内皮生长因子受体-1(sFlt-1)在子痫前期孕妇血清中的表达水平及意义。方法选择子痫前期孕妇共41例,其中轻度子痫前期组15例,重度子痫前期组26例;随机选取同期正常妊娠孕妇40例为对照组,采用酶联免疫吸附法检测各组孕妇血清sEng和sFlt-1水平。结果轻、重度子痫前期组血清sEng和sFlt-1均高于对照组,差异有统计学意义(P<0.05)。重度子痫前期组血清sEng水平高于轻度子痫前期组,差异有统计学意义(P<0.05)。子痫前期并发FGR孕妇血清sEng和sFlt-1水平高于未并发FGR孕妇,差异有统计学意义(P<0.05)。子痫前期孕妇血清sEng水平与MAP呈正相关(r=0.571,P<0.05);sFlt-1水平与24 h尿蛋白量呈正相关(r=0.466,P<0.05)。子痫前期孕妇血清sEng与sFlt-1水平呈正相关(r=0.570,P<0.05)。结论孕妇血清sEng和sFlt-1水平升高,可能与子痫前期和FGR发病有关,两者在子痫前期作用的方向可能不同并且存在协同作用。
作者 何平 郑婕
出处 《广东医学》 CAS CSCD 北大核心 2011年第24期3206-3208,共3页 Guangdong Medical Journal
  • 相关文献

参考文献10

  • 1VENKATESHA S,TOPORSIAN M,LAM C,et al.Soluble endoglin contribu-tes to the pathogenesis of preeclampsia[J].Nat Med,2006,12(6):642-649.
  • 2TSATSARIS V,GOFFIN F,MUNAUT C.Overexpression of the soluble vas-cular endothelial growth factor receptor in preeclamptic patients:pathophysiological consequences[J].J Clin Endocrinol Metab,2003,88(11):5555-5563.
  • 3SALAHUDDIN S,LEE Y,VADNAIS M,et al.Diagnostic utility of solub-le fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy[J].Am J Obstet Gynecol,2007,197(1):28.e1-6.
  • 4LEE E S,OH M J,JUNG J W,et al.The levels of circulating vascular endothelial growth factor and soluble sFlt-1 in pregnancies compli-cated by preeclampsia[J].J Korean Med Sci,2007,22(1):94-98.
  • 5GIRARDI G,YARILIN D,THURMAN J M,et al.Complement activation ind-uces dysregulation of angiogenic factors and causes fetal rejection and growthrestriction[J].J Exp Med,2006,203(9):2165-2175.
  • 6LEVINE R J,LAM C,QIAN C,et al.Soluble endoglin and other circul-ateing antiangiogenic factors in preeclampsia[J].N Engl J Med,2006,355(10):992-1005.
  • 7LI H,GU B,ZHANG Y,et al.Hypoxia induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophobla-st cells from the human placenta[J].Placenta,2005,26(2/3):210-217.
  • 8BELLAMY L,CASAS J P,HINGORANI A D,et al.Preeclampsia and risk of cardiovascular disease and cancer in later life:systematic review and meta analysis[J].BMJ,2007,335(7627):974.
  • 9WOLF M,HUBEL C A,LAM C,et al.Preeclampsia and future cardiovascular disease:potential role of altered angiogenesis and insulin resistance[J].J Clin Endocrinol Metab,2004,89(12):6239-6243.
  • 10CHAN P,BROWN M,SIMPSON J M,et al.Proteinuria in pre-eclampsia:how much matters?[J].BJOG,2005,112(3):280-285.

同被引文献60

  • 1尹彩云.妊高症患者凝血参数变化的临床意义[J].临床检验杂志(电子版),2013,2(2):367-369. 被引量:6
  • 2李玉山,张曦,张展,鄢文海,贾莉婷,胡玉芬.妊娠期高血压疾病患者血清IL-6、TNF-α检测[J].郑州大学学报(医学版),2005,40(3):469-470. 被引量:2
  • 3杨晓华,艾瑛,杨沛,刘兴会.182例重度子痫前期和子痫的分析[J].华西医学,2006,21(1):106-107. 被引量:21
  • 4陈丽红,李云,胡继芬.子痫时可溶性血管内皮生长因子受体1的变化[J].中华高血压杂志,2007,15(7):541-544. 被引量:5
  • 5Lee ES,Oh MJ,Jung JW,et al. The levels of circulatingvascular endothelial growth factor and soluble Flt-1 in pregn-ancies complicated by preeclampsia [J]. J Korean Med Sci,' 2007,22:94-98.
  • 6Wathen KA,Tuutti E,Stenman UH,et al. Maternal serum-soluble vascular endothelial growth factor receptor-1 in earlypregnancy ending in preeclampsia or intrauterine growthretardation [ J ]. J Clin Endocrinol Metab,2006,91:180-184.
  • 7Chaiworapongsa T,Romero R’Kim YM,et al. Plasma solublevascular endothelial growth factor receptor-1 concentration iselevated prior to the clinical diagnosis of pre-eclampsia[J]. JMatern Fetal Neonatal Med,2005,17 :3-18.
  • 8Venkatesha S,Toporsian M,Lam C, et al. Soluble endoglincontributes to the pathogenesis of preeclampsia[J]. Nat Med,2006,12:642-649.
  • 9Girardi G, Yarilin D,Thurman JM, et al. Complementactivation induces dysregulation of angiogenic factors andcauses fetal rejection and growth restriction[J]. J Exp Med,2006,203:2165-2175.
  • 10Wolf M, Hubei CA, Lam C,et al. Preeclampsia and futurecardiovascular disease: potential role of altered angiogenesisand insulin resistance[J]. J Clin Endocrinol Metab,2004,89 :6239-6243.

引证文献8

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部